Search
Showing results for "1"
Research
Prednisolone Versus Dexamethasone for Croup: a Randomized Controlled TrialThe type of oral steroid seems to have no clinically significant impact on efficacy, both acutely and during the week after treatment
Research
The Benefits to Bone Health in Children and Pre-School Children with Additional Exercise Interventions: A Systematic Review and Meta-AnalysisDetermine if exercise interventions, beyond what is already provided to children and preschool children, improve bone health and reduce fracture incidence.
News & Events
PCH takes lead in Diabetes In Schools programPerth Children’s Hospital will be one of the first hospitals in Australia to deliver critical diabetes training to teachers and school staff as part of a new national Diabetes in Schools program.
News & Events
ENDIA milestoneThe ENDIA study — Australia’s largest study into the causes of Type 1 Diabetes— reached a significant milestone when it recruited its 700th patient in Perth.
News & Events
Testing how much protein is needed to prevent overnight hypos which can happen after exerciseWe're testing how much protein is needed to prevent overnight hypos which can happen after exercise
Research
Association between male genital anomalies and adult male reproductive disorders: a population-based data linkage study spanning more than 40 yearsWe provide new evidence to support current guidelines for orchidopexy before age 18 months to decrease the risk of future testicular cancer and infertility
Read about the research fellows at the Children's Diabetes Centre, Martin de Bock, Aveni Hayes, Ashleigh Lin and Marie-Anne Burckhardt.
News & Events
In other news ....Diabetes-related news, funding announcements and our latest published research.
News & Events
Meat mattersType 1 diabetes patients require about 50 per cent more insulin with a high protein meal then with a low protein meal to maintain a stable blood glucose level, according to new research from the Children’s Diabetes Centre at The Kids Research Institute Australia.
Research
CGM accuracy: Contrasting CE marking with the governmental controls of the USA (FDA) and Australia (TGA): A narrative reviewThe National Institute for Clinical Excellence updated guidance for continuous glucose monitoring (CGM) in 2022, recommending that CGM be available to all people living with type 1 diabetes. Manufacturers can trade in the UK with Conformité Européenne (CE) marking without an initial national assessment. The regulatory process for CGM CE marking, in contrast to the Food and Drug Administration (FDA) and Australian Therapeutic Goods Administration (TGA) process, is described.